Evidence map›Paper›PMID 41492829›Full record

ArticleJournal of viral hepatitis2026

Trends of Advanced Chronic Liver Disease Among 17,711 Persons in Mongolia During Years 2015-2023.

Habiba Kamal, Ganbolor Jargalsaikhan, Sanjaasuren Enkhtaivan, Daniel Bruce, Karin Lindahl, Bekhbold Dashtseren, Tuvshinjargal Ulziibadrakh, Munguntsetseg Batkhuu, Purevjargal Bat-Ulzii, Sumiya Byambabaatar and 2 more

Abstract read
In one paragraph

Article in Journal of viral hepatitis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Habiba KamalDepartment of Medicine Huddinge, Karolinska Institute, Stockholm, Sweden.ORCID 0000-0002-6662-7813
Ganbolor JargalsaikhanThe Liver Centre, Ulaanbaatar, Mongolia.
Sanjaasuren EnkhtaivanThe Liver Centre, Ulaanbaatar, Mongolia.
Daniel BruceCytel Statistical Consultancy, Stockholm, Sweden.
Karin LindahlDepartment of Medicine Huddinge, Karolinska Institute, Stockholm, Sweden.
Bekhbold DashtserenThe Liver Centre, Ulaanbaatar, Mongolia.ORCID 0000-0002-7160-1976
Tuvshinjargal UlziibadrakhThe Liver Centre, Ulaanbaatar, Mongolia.
Munguntsetseg BatkhuuThe Liver Centre, Ulaanbaatar, Mongolia.
Purevjargal Bat-UlziiThe Liver Centre, Ulaanbaatar, Mongolia.
Sumiya ByambabaatarThe Liver Centre, Ulaanbaatar, Mongolia.
Soo AlemanDepartment of Medicine Huddinge, Karolinska Institute, Stockholm, Sweden.ORCID 0000-0003-0461-4870
Naranjargal B DashdorjThe Liver Centre, Ulaanbaatar, Mongolia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic liver diseases cause a significant burden in Asia. This study aims to characterise the pattern and factors associated with advanced chronic liver disease (aCLD) in a large cohort from Mongolia, which has the highest rate of liver cancer globally. This is a cross-sectional analysis of HBsAg tested adults (≥ 18 years) with available liver stiffness measurement (LSM) and/or platelet count at initial visit at a hepatology centre, Ulaanbaatar, Mongolia during 2015-2023. Definition of aCLD was LSM ≥ 12.5 kPa or platelet count < 150*10

Indexed as

Liver NeoplasmsAdultAgedCross-Sectional StudiesFemaleHepatitis B, ChronicHepatitis B Surface AntigensHumansIncidenceLiver CirrhosisMaleMiddle AgedMongoliaPrevalenceRisk FactorsYoung AdultHepatitis B Surface AntigenscirrhosisHBVHCVHDVmongolia

Identifiers

PMID41492829
PMCPMC12771268

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.